By [Your Name/Journalist], Sleep Review
At 87 years old, Dr. Magdy Younes, MD, FRCP(C), PhD, is not slowing down; he is accelerating. A titan in the field of sleep medicine and respiratory physiology, Younes has spent decades decoding the complex electrical signals of the human brain during slumber. His life’s work—centered on the Odds Ratio Product (ORP)—is now at a critical juncture. In a move aimed at securing his scientific legacy and propelling the future of sleep research, Younes has announced that he is opening broad access to the ORP metric and its derivatives through his company, YRT Limited.
For Younes, this is a race against time. He is determined to see his revolutionary metrics validated and integrated into the global clinical mainstream before he leaves the field. "The science is ready," Younes suggests. "The challenge has never been the data; it has been the delivery."
The Genesis of a Metric: Understanding the Odds Ratio Product
To understand the urgency behind Dr. Younes’ initiative, one must first understand what the Odds Ratio Product actually represents. Traditional sleep scoring, governed by the American Academy of Sleep Medicine (AASM) guidelines, relies heavily on discrete, epoch-based staging. While useful for general diagnosis, this "macro" view often misses the nuances of sleep depth—the subtle physiological shifts that occur within seconds, not minutes.
The ORP provides a continuous, high-resolution measure of sleep depth. By analyzing the power spectral density of EEG data, the ORP produces a value ranging from 0 (deepest sleep) to 2.5 (full wakefulness). Unlike traditional staging, which categorizes sleep into rigid buckets (N1, N2, N3, REM), ORP offers a granular, objective, and continuous scale. It allows researchers to see exactly how a patient’s sleep depth fluctuates in response to respiratory events, medications, or neurological pathologies.
The Rise and Fall of the Commercial Vehicle
The ORP metric gained significant attention through its implementation by Cerebra Health. For a time, it appeared that the metric would become the industry standard for home sleep apnea testing (HSAT). However, the partnership proved to be a strategic mismatch. Cerebra shuttered its operations in early 2025, leaving many researchers and clinicians concerned about the future availability of ORP-based analysis.
Dr. Younes is characteristically candid about why the previous iteration failed to achieve mass adoption. "The bottleneck was never the ORP," he explains. "The bottleneck was the hardware." By tethering the ORP analysis to a specific Type II sleep testing system, the commercial strategy inadvertently limited the metric’s reach. In the landscape of healthcare reimbursement and clinical logistics, the industry was not prepared to pivot toward a new, albeit superior, diagnostic standard tied to a single, proprietary device.
A Chronology of Innovation: From Labs to Algorithms
The journey of Dr. Younes is one of relentless curiosity. His career spans over five decades, marked by pivotal discoveries in the mechanics of obstructive sleep apnea (OSA) and the control of breathing.
- 1970s–1990s: Younes establishes foundational research into the loop gain of the respiratory control system, providing the theoretical framework for understanding why some patients experience instability in their breathing during sleep.
- 2000s: The shift toward digital signal processing allows Younes to move beyond visual scoring. He begins developing algorithms that can quantify sleep depth automatically, removing the inter-scorer variability that has plagued sleep medicine for decades.
- 2010s: The Odds Ratio Product is formalized. Studies demonstrate that ORP is more sensitive to sleep fragmentation and more predictive of daytime performance than traditional apnea-hypopnea index (AHI) metrics.
- 2020–2025: The integration of ORP into the Cerebra platform provides proof-of-concept for clinical settings, yet the reliance on proprietary Type II hardware limits broad uptake.
- 2025–Present: Following the closure of Cerebra, Younes establishes YRT Limited as a dedicated vehicle to democratize the ORP metric. By uncoupling the algorithm from specific hardware, he aims to make ORP available for all polysomnographic data, regardless of the recording device.
Supporting Data: Why ORP Matters in Modern Medicine
The case for ORP rests on the limitations of current diagnostic protocols. The AHI, the current gold standard for diagnosing OSA, is widely acknowledged to be a flawed metric. It measures the frequency of events but fails to account for the physiological impact of those events on the brain’s ability to remain in deep, restorative sleep.
Research utilizing ORP has consistently shown that:
- Sensitivity to Fragmentation: ORP can detect "micro-arousals" that do not meet the AASM’s 3-second threshold for scoring, yet still result in significant sleep instability.
- Predictive Accuracy: Higher ORP values during sleep are correlated with higher scores on the Epworth Sleepiness Scale (ESS) and objective measures of daytime vigilance, whereas AHI often shows a weak correlation with patient symptoms.
- Universal Compatibility: Because ORP is derived from standard EEG leads (C3/C4 or O1/O2), it can be retroactively applied to any in-lab Type I polysomnography (PSG) study. This is a game-changer for academic institutions holding massive archives of historical sleep data.
The Path Forward: YRT Limited and the Open-Access Model
By forming YRT Limited, Dr. Younes is effectively shifting the paradigm from a "product-based" model to a "service-based" model. His goal is to provide researchers and clinicians with the ability to score studies—be they historical datasets or new clinical trials—using the ORP methodology.
Addressing the Cost Barrier
A common critique of advanced diagnostic algorithms is the cost of implementation. YRT Limited has adopted a radical pricing strategy: for research projects, fees are determined strictly at cost. This is not about building a software monopoly; it is about scientific validation. "I want the data to speak for itself," says Younes. "If the metric is as valuable as the research suggests, it should be the standard tool for every sleep laboratory in the world."
The technical process involves transmitting de-identified PSG files to YRT Limited, where the proprietary algorithms generate an ORP report. This allows investigators to bypass the need for expensive, dedicated diagnostic hardware and utilize the equipment they already have on-site.
Implications for the Field of Sleep Medicine
The implications of this move are profound. If the global sleep medicine community adopts ORP as a secondary or primary metric, the way we define "normal" and "pathological" sleep will change.
A Shift in Clinical Practice
Clinicians have long struggled with the "asymptomatic patient with high AHI" or the "symptomatic patient with low AHI." These patients fall through the cracks of current diagnostic criteria. ORP offers a way to see the "why." If a patient has a high AHI but a low average ORP, their sleep architecture may be resilient to those events. Conversely, a patient with a low AHI but a high, unstable ORP may be suffering from significant sleep-related morbidity that currently goes untreated.
Transforming Drug Discovery
For pharmaceutical companies, the ability to objectively measure sleep depth is a "holy grail." Currently, many sleep drugs are evaluated based on subjective patient reports or coarse staging. ORP provides a high-resolution, quantitative endpoint for clinical trials, potentially shortening the time to market for new sleep therapies and allowing for more precise dosing and efficacy studies.
Official Response and Future Outlook
The sleep medicine community has reacted with cautious optimism. While some remain wedded to the AASM-mandated staging, a growing cadre of "Young Turks" in the field—researchers who have grown up with digital signal processing—are eager to embrace the ORP.
Dr. Younes remains the primary champion of this shift. He invites interested investigators, clinicians, and academic centers to reach out to YRT Limited directly. The invitation is open: utilize the ORP for your research, validate it in your patient populations, and join the effort to standardize the measurement of human sleep.
As he looks toward the future, Younes is clear-eyed about the work that remains. "The goal is not to replace the sleep technician or the physician," he clarifies. "The goal is to provide them with a better lens through which to see the patient’s reality."
For the 87-year-old pioneer, this final chapter is not about commerce; it is about stewardship. By opening the doors to his life’s work, he is ensuring that the ORP will not die with him, but will instead become the foundation upon which the next century of sleep science is built.
For those interested in collaborating or utilizing ORP services, YRT Limited is currently accepting inquiries. Please visit their official contact portal to discuss potential projects and research collaborations.
